These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 31491431

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine.
    Hankaniemi MM, Stone VM, Sioofy-Khojine AB, Heinimäki S, Marjomäki V, Hyöty H, Blazevic V, Laitinen OH, Flodström-Tullberg M, Hytönen VP.
    Vaccine; 2019 Sep 20; 37(40):5962-5971. PubMed ID: 31471148
    [Abstract] [Full Text] [Related]

  • 3. Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine.
    Hankaniemi MM, Baikoghli MA, Stone VM, Xing L, Väätäinen O, Soppela S, Sioofy-Khojine A, Saarinen NVV, Ou T, Anson B, Hyöty H, Marjomäki V, Flodström-Tullberg M, Cheng RH, Hytönen VP, Laitinen OH.
    Microorganisms; 2020 Aug 24; 8(9):. PubMed ID: 32846899
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model.
    Hankaniemi MM, Laitinen OH, Stone VM, Sioofy-Khojine A, Määttä JAE, Larsson PG, Marjomäki V, Hyöty H, Flodström-Tullberg M, Hytönen VP.
    Vaccine; 2017 Jun 27; 35(30):3718-3725. PubMed ID: 28579231
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
    Zhang L, Parham NJ, Zhang F, Aasa-Chapman M, Gould EA, Zhang H.
    Vaccine; 2012 Mar 16; 30(13):2301-8. PubMed ID: 22306858
    [Abstract] [Full Text] [Related]

  • 10. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H, Sedano M, Plata G, Punke EB, Joshi A.
    J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28794019
    [Abstract] [Full Text] [Related]

  • 11. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z, Liu Q, Ye X, Cai Y, Wang X, Shi J, Li D, Jin X, An W, Huang Z.
    Vaccine; 2014 Jul 23; 32(34):4296-303. PubMed ID: 24950363
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models.
    Larsson PG, Lakshmikanth T, Laitinen OH, Utorova R, Jacobson S, Oikarinen M, Domsgen E, Koivunen MR, Chaux P, Devard N, Lecouturier V, Almond J, Knip M, Hyöty H, Flodström-Tullberg M.
    Diabetologia; 2015 Feb 23; 58(2):346-54. PubMed ID: 25370797
    [Abstract] [Full Text] [Related]

  • 16. Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections.
    Shen C, Ku Z, Zhou Y, Li D, Wang L, Lan K, Liu Q, Huang Z.
    Vaccine; 2016 Jul 25; 34(34):4025-31. PubMed ID: 27340093
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates.
    Lim PY, Hickey AC, Jamiluddin MF, Hamid S, Kramer J, Santos R, Bossart KN, Cardosa MJ.
    Vaccine; 2015 Nov 04; 33(44):6017-24. PubMed ID: 26271825
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.